Financials · BCPC

Balchem Corporation (BCPC) financials

For the twelve months ended Sep 30, 2026, Balchem Corporation reported $1.11B of revenue and $170.85M of net income.

Revenue, TTM
$1.11B
Revenue growth, YoY
+9.4%
Net income, TTM
$170.85M
Net income growth, YoY
+14.5%
Net margin
15.4%
EPS, diluted, TTM
$5.31
EPS growth, YoY
+16.2%
Cash
$66.26M
P/E
32.73
P/S
5.04
Market cap
$5.59B
Annual revenue$1.04B
FY2016FY2025
Annual net income$154.84M
FY2016FY2025
Annual free cash flow$89.45M
FY2016FY2022

BCPC revenue and earnings growth

BCPC revenueQ3 2026$290.66M

Quarter YoY
+8.6%
QoQ
+2.3%
FY YoY
+8.8%
5Y CAGR
+8.1%
10Y CAGR
+6.5%

BCPC revenue was $290.66M in fiscal Q3 2026 (ended Sep 30, 2026), up 8.6% from a year earlier and up 2.3% from the prior quarter. For the full fiscal 2025 it was $1.04B, up 8.8% from fiscal 2024. Compound annual growth was +8.1% over 5 years and +6.5% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

BCPC net incomeQ3 2026$46.73M

Quarter YoY
+16.0%
QoQ
+4.7%
FY YoY
+20.5%
5Y CAGR
+12.8%
10Y CAGR
+10.0%

BCPC net income was $46.73M in fiscal Q3 2026 (ended Sep 30, 2026), up 16.0% from a year earlier and up 4.7% from the prior quarter. For the full fiscal 2025 it was $154.84M, up 20.5% from fiscal 2024. Compound annual growth was +12.8% over 5 years and +10.0% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

BCPC EPSQ3 2026$1.46

Quarter YoY
+17.7%
QoQ
+5.0%
FY YoY
+20.9%
5Y CAGR
+12.8%
10Y CAGR
+9.7%

BCPC diluted EPS was $1.46 in fiscal Q3 2026 (ended Sep 30, 2026), up 17.7% from a year earlier and up 5.0% from the prior quarter. For the full fiscal 2025 it was $4.75, up 20.9% from fiscal 2024. Compound annual growth was +12.8% over 5 years and +9.7% over 10 years.

Export CSV

Income statement

Income statement
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue$1.04B$953.68M$922.44M$942.36M$799.02M$703.64M$643.71M$643.68M$594.79M$553.20M
Cost of revenue$666.53M$617.48M$620.38M$661.91M$555.85M$479.75M$432.34M$439.43M$405.78M$372.34M
Gross profit$370.63M$336.21M$302.06M$280.45M$243.17M$223.90M$211.37M$204.25M$189.01M$180.86M
Research and development$18.51M$16.79M$15.05M$12.19M$13.52M$10.33M$11.38M$11.59M$9.30M$7.33M
Selling, general and admin$67.42M$67.59M$53.42M$55.66M$41.73M$43.79M$36.51M$28.34M$28.08M$27.53M
Operating income$209.33M$182.91M$159.19M$145.19M$127.50M$111.15M$102.55M$107.10M$96.90M$90.84M
Interest expense--------$7.54M$7.26M
Pre-tax income$199.03M$166.45M$137.26M$133.75M$125.23M$106.42M$96.48M$99.03M$88.49M$82.93M
Income tax$44.19M$37.98M$28.72M$28.38M$29.13M$21.79M$16.81M$20.46M-$1.58M$26.96M
Net income$154.84M$128.47M$108.54M$105.37M$96.10M$84.62M$79.67M$78.57M$90.07M$55.97M
EPS, basic$4.80$3.97$3.38$3.29$2.98$2.63$2.48$2.45$2.83$1.78
EPS, diluted$4.75$3.93$3.35$3.25$2.94$2.60$2.45$2.42$2.79$1.75
Diluted shares32.6M32.7M32.4M32.4M32.7M32.5M32.5M32.4M32.2M31.9M

Balance sheet

Balance sheet
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Cash and equivalents$74.57M$49.52M$64.45M$66.56M$103.24M$84.57M$65.67M$54.27M$40.42M$38.64M
Receivables$143.60M$119.66M$125.28M$131.58M$117.41M$98.21M$93.44M$99.55M$91.23M$83.25M
Inventory$131.45M$130.80M$109.52M$119.67M$91.06M$70.62M$83.89M$67.19M$60.70M$57.24M
Current assets$365.61M$313.77M$314.24M$335.80M$322.23M$266.89M$254.95M$226.31M$199.34M$188.44M
Goodwill$816.38M$780.03M$778.91M$769.51M$523.95M$529.46M$524.00M$448.00M$441.36M$439.81M
Total assets$1.69B$1.58B$1.60B$1.62B$1.20B$1.17B$1.16B$981.36M$963.64M$948.63M
Current liabilities$176.38M$157.69M$148.49M$140.04M$143.80M$94.43M$92.26M$82.06M$108.40M$101.01M
Short-term debt------$2.48M$0$35.00M$35.00M
Long-term debt-------$156.00M$0$226.49M
Total debt-------$156.00M$35.00M$261.49M
Total liabilities$428.84M$425.46M$543.23M$686.23M$322.31M$337.61M$412.01M$289.74M$346.75M$427.59M
Shareholders' equity$1.26B$1.15B$1.05B$938.28M$877.01M$828.23M$743.67M$691.62M$616.88M$521.03M

Cash flow

Cash flow
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Operating cash flow$216.56M$182.00M$183.76M$138.54M$160.51M$150.49M$124.46M$118.70M$110.62M$107.61M
Capital expenditures---$49.09M$36.14M$32.08M$25.79M$19.17M$27.53M$23.03M
Free cash flow---$89.45M$124.37M$118.41M$98.67M$99.53M$83.09M$84.58M
Investing cash flow-$43.89M-$59.74M-$34.81M-$416.01M-$35.30M-$34.59M-$156.22M-$31.99M-$42.70M-$133.59M
Financing cash flow-$152.81M-$133.81M-$153.32M$246.68M-$102.18M-$101.16M$43.38M-$71.45M-$68.63M-$19.45M
Dividends paid$28.29M$25.58M$22.87M$20.71M$18.72M$16.70M$15.13M$13.43M$12.07M$10.72M
Share repurchases$107.64M$5.68M$4.47M$35.42M$35.24M$13.46M$21.32M$1.39M$1.91M$1.59M
Stock-based compensation$18.06M$16.68M$16.05M$13.22M$10.80M$8.30M$7.60M$6.41M$6.26M$7.02M
Depreciation and amortization$45.69M$47.97M$54.94M$51.85M$48.88M$51.28M$45.86M$44.67M$44.38M$46.20M

Key ratios

Key ratios
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Revenue growth, YoY8.8%3.4%-2.1%17.9%13.6%9.3%0.0%8.2%7.5%0.1%
Net income growth, YoY20.5%18.4%3.0%9.6%13.6%6.2%1.4%-12.8%60.9%-6.3%
EPS growth, YoY20.9%17.3%3.1%10.5%13.1%6.1%1.2%-13.3%59.4%-7.4%
Gross margin35.7%35.3%32.7%29.8%30.4%31.8%32.8%31.7%31.8%32.7%
Operating margin20.2%19.2%17.3%15.4%16.0%15.8%15.9%16.6%16.3%16.4%
Net margin14.9%13.5%11.8%11.2%12.0%12.0%12.4%12.2%15.1%10.1%
Free cash flow margin---9.5%15.6%16.8%15.3%15.5%14.0%15.3%
Return on equity12.3%11.2%10.3%11.2%11.0%10.2%10.7%11.4%14.6%10.7%
Return on assets9.2%8.2%6.8%6.5%8.0%7.3%6.9%8.0%9.3%5.9%
Current ratio2.071.992.122.402.242.832.762.761.841.87
Debt to equity-------0.230.060.50

Source: XBRL data Balchem Corporation files with the SEC, latest filing dated Oct 23, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

BCPC peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
BCPC$1.11B+9.4%$170.85M15.4%$5.59B
LIN$36.24B+8.2%$7.01B19.3%$238.88B
APD$12.60B+4.5%-$47.30M-0.4%$69.27B
DOW$42.61B+4.2%-$897.00M-2.1%$22.41B
IFF$11.69B+24.3%$182.00M1.6%$21.14B
DD$7.06B+3.2%$301.00M4.3%$20.56B
LYB$31.96B+3.5%$1.30B4.1%$19.23B
ALB$6.15B+24.4%$681.63M11.1%$11.70B
SOLS$4.17B+9.4%$325.00M7.8%$10.01B

BCPC FAQ

8 questions
  • What is BCPC revenue?
    Balchem Corporation (BCPC) reported $1.11B of revenue for the twelve months ended Sep 30, 2026. That is up 9.4% from the year before. Revenue for fiscal 2025 was $1.04B.
  • Is BCPC profitable?
    Yes. Balchem Corporation earned $170.85M in net income for the twelve months ended Sep 30, 2026, a net margin of 15.4%.
  • How much cash and debt does BCPC have?
    Balchem Corporation reported $66.26M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • How fast is BCPC revenue growing?
    Balchem Corporation's revenue changed +8.8% in fiscal 2025, to $1.04B. Its compound annual growth rate was +8.1% over 5 years and +6.5% over 10 years.
  • What is BCPC gross margin?
    Balchem Corporation's gross profit was $404.38M on $1.11B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 36.5%.
  • What is BCPC earnings per share?
    Diluted earnings per share were $5.31 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did BCPC last report financial results?
    The latest statements here come from Balchem Corporation's 10-Q filed on Oct 23, 2026, covering the period ended Sep 30, 2026.
  • Where does this BCPC financial data come from?
    Quantisnow builds these statements from the structured XBRL data Balchem Corporation files with the SEC. It is provided for information only and is not investment advice.